📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The use of PARP inhibitors in cancer therapy: use as adjuvant with chemotherapy or radiotherapy; use as a single agent in susceptible patients; techniques used to identify susceptible patients. (2011)

First Author: Shall S

Attributed to: BRIC: Packaging cell lines for inherently manufacturable viral vectors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/978-1-61779-270-0_15

PubMed Identifier: 21870265

Publication URI: http://europepmc.org/abstract/MED/21870265

Type: Journal Article/Review

Volume: 780

Parent Publication: Methods in molecular biology (Clifton, N.J.)

ISSN: 1064-3745